![[Corrigendum] Integrative transcriptomic analysis unveils FXR as a key regulator of intestinal stemness and inflammation in ulcerative colitis](https://www.spandidos-publications.com/resources/images/ijmm.jpg)
International Journal of Molecular Medicine
Cure8 research brief
Why This Matters
Accurate methods and dataset labels matter for researchers reproducing transcriptomic analyses and for clinicians interpreting translational implications. The corrigendum clarifies which datasets and experimental models were used and fixes labeling errors without changing the paper’s conclusions.
Who Should Pay Attention
Researchers, bioinformaticians, and clinicians who read or plan to reproduce the study; investigators using GSE116222 or GSE87466; IBD translational researchers.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthMetadata only
What To Know
The notice does not report new experimental results — it corrects methods and labeling details in the original paper so that readers can accurately interpret the analyses (which involve single‑cell RNA sequencing and bulk transcriptomic co‑expression analysis). The authors state these changes do not alter the paper's results or conclusions.
The corrigendum also clarifies that some images derive from a DSS mouse model rather than human samples.
Keep In Mind
This is a corrigendum (correction) to a published research article in the International Journal of Molecular Medicine. The authors state the corrections do not affect the study’s results or conclusions. The notice clarifies dataset usage (single‑cell versus bulk), corrects mouse vs human labeling in a figure, and fixes a typographical error in demographic reporting.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational Journal of Molecular Medicine
PublisherSpandidos Publications
AuthorsHao Lin, Xinran Cheng, Yangyang Ren +4 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 14, 2026, 12:00 AM
Content availableMetadata only
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Multi-omics analysis identifies macrophage immunometabolic signatures in ulcerative colitis
The work highlights macrophage metabolic programs and specific genes that may help classify UC molecular subtypes and suggest candidate biomarkers or therapeutic targets related to macrophage-driven inflammation.
Integrated Transcriptomic and Machine-Learning Analyses Identify Shared Na+ Overload-Related Gene Signatures in Inflammatory Bowel Disease and Ankylosing Spondylitis
The study links shared gene-expression patterns between IBD and ankylosing spondylitis and highlights STAT3 as a potential shared biomarker or therapeutic target, which could be relevant for understanding overlapping...
Multi-omics Mendelian randomization and experimental validation identify PRKAB1 as a regulator of phosphatidylcholine metabolism in IBD.
Phosphatidylcholines are implicated in IBD biology; identifying a gene that regulates PC metabolism could point to new mechanistic targets. If PRKAB1 modulates epithelial lipid metabolism relevant to inflammation, it may...